Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New developments in immunopathology with special reference to complement and immune complexes.

M M Frank

    International Archives of Allergy and Applied Immunology
    |January 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Complement activation.

    Immunology today·2014
    Same author

    Wild-type adenoviruses from groups A-F evoke unique innate immune responses, of which HAd3 and SAd23 are partially complement dependent.

    Gene therapy·2008
    Same author

    Recombinant adenovirus vectors activate the alternative complement pathway, leading to the binding of human complement protein C3 independent of anti-ad antibodies.

    Molecular therapy : the journal of the American Society of Gene Therapy·2004
    Same author

    Complement activation influences Staphylococcus aureus adherence to endothelial cells.

    Infection and immunity·2003
    Same author

    Availability of complement bound to Staphylococcus aureus to interact with membrane complement receptors influences efficiency of phagocytosis.

    Infection and immunity·2003
    Same author

    Complement 1 inhibitor is a regulator of the alternative complement pathway.

    The Journal of experimental medicine·2001
    Same journal

    Epidemiology of the relationship between exposure to indoor allergens and asthma.

    International archives of allergy and applied immunology·1991
    Same journal

    T cells and asthma. II. Regulation of the eosinophilia of asthma by T cell cytokines.

    International archives of allergy and applied immunology·1991
    Same journal

    T cells and asthma. I. Lymphocyte subpopulations and activation in allergic and nonallergic asthma.

    International archives of allergy and applied immunology·1991
    Same journal

    Human upper airway epithelial cell-derived granulocyte-macrophage colony-stimulating factor induces histamine-containing cell differentiation of human progenitor cells.

    International archives of allergy and applied immunology·1991
    Same journal

    Detection of antidrug IgG antibodies in patients with adverse drug reactions to amodiaquine.

    International archives of allergy and applied immunology·1991
    Same journal

    Effects of the platelet-activating factor antagonist BN 52021 on anti-islet cytotoxicity of mononuclear cells and serum from type 1 (insulin-dependent) diabetic patients.

    International archives of allergy and applied immunology·1991
    See all related articles

    Recent advances illuminate how complement proteins and immune complexes drive immunopathology. This knowledge enhances understanding of disease mechanisms and aids in developing new diagnostic tools for complement-mediated damage.

    Area of Science:

    • Immunology
    • Pathology
    • Molecular Medicine

    Background:

    • Significant progress has been made in understanding immune system phenomena.
    • These advances are crucial for understanding immunopathology.
    • The complement system and immune complexes are key areas of focus.

    Purpose of the Study:

    • To review recent advancements in the role of complement and immune complexes in disease.
    • To highlight new knowledge regarding complement metabolism and its interaction with receptors.
    • To discuss the implications of these findings for diagnostics and understanding disease mechanisms.

    Main Methods:

    • Review of recent scientific literature on complement and immune complexes.
    • Analysis of studies on complement protein metabolism and receptor interactions.

    Related Experiment Videos

  • Examination of research on lysis-producing pathways and anaphylatoxins.
  • Inclusion of a human serum sickness model for immune-complex disease study.

    • Main Results:

    • New insights into complement protein metabolism and receptor interactions.
    • Development of novel diagnostic tests for complement-induced damage.
    • Enhanced understanding of complement's role in microbial killing.
    • Availability of purified anaphylatoxins for human studies.
    • Detailed understanding of immune complexes causing disease via a serum sickness model.

    Conclusions:

    • Advances in understanding complement and immune complexes are transforming immunopathology.
    • New knowledge facilitates improved diagnostics for complement-mediated conditions.
    • The study of immune complexes offers insights into clinical signs of related diseases.